Confusable diagnoses · PANCE / PANRE

Squamous Cell Carcinoma vs Actinic Keratosis

Written & clinically reviewed by Ryan Busch, PA-C · Updated August 2026 · Report an error

Squamous Cell Carcinoma and Actinic Keratosis are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.

Squamous Cell Carcinoma vs Actinic Keratosis at a glance

  • Squamous Cell Carcinoma: Second most common skin cancer; UV-driven keratinocyte malignancy with real metastatic potential, especially in immunosuppressed.
  • Actinic Keratosis: UV-induced precancerous keratinocyte lesion on sun-damaged skin; low per-lesion risk of progression to invasive SCC, but the precursor of most cutaneous SCCs.

Try two board-style questions on Squamous Cell Carcinoma vs Actinic Keratosis

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1DermatologyEasy
A 72-year-old male with multiple actinic keratoses has a firm, indurated, 1.8 cm ulcerated nodule with raised, everted borders on his right cheek. It bleeds easily on contact. There is no regional lymphadenopathy. Which of the following is the most likely diagnosis?
  • AActinic keratosis
  • BBasal cell carcinoma
  • CCutaneous squamous cell carcinoma
  • DKeratoacanthoma
Reveal answer & full explanation
Correct answer: C — Cutaneous squamous cell carcinoma
  • AActinic keratosis
  • BBasal cell carcinoma
  • CCutaneous squamous cell carcinoma✓
  • DKeratoacanthoma

Why cutaneous squamous cell carcinoma is correct

  • Firm indurated ulcerated nodule with raised, everted borders on the sun-exposed face in an elderly patient with actinic field changes is classic for cutaneous squamous cell carcinoma (cSCC)
  • Treatment: biopsy to confirm, then Mohs micrographic surgery for facial location (head and neck, ears) — confirms complete excision with margin control while minimizing tissue removal on cosmetically sensitive areas
  • Standard excision (4–6 mm margins) is acceptable for low-risk tumors on trunk and extremities

Why the others are wrong

  • Actinic keratosis — a precancerous, scaly erythematous macule/papule with a rough "sandpaper" feel, not a firm indurated ulcerated nodule; induration, ulceration, and easy bleeding signal progression to invasive cSCC
  • Basal cell carcinoma — typically a pearly, translucent papule with rolled (not everted) borders and telangiectasias that ulcerates centrally ("rodent ulcer"); it lacks the firm everted-border nodular morphology and rarely arises directly within actinic keratoses
  • Keratoacanthoma — a rapidly growing dome-shaped nodule with a central keratin-filled crater that often regresses spontaneously, rather than a persistent ulcerated lesion with raised everted borders that bleeds on contact

Additional high-yield points

  • High-risk cSCC features indicating potential nodal workup: size over 2 cm, depth over 6 mm or invasion beyond subcutaneous fat, poorly differentiated, perineural invasion, immunosuppressed patient
  • Cemiplimab (anti-programmed cell death protein 1 (PD-1)): approved for locally advanced or metastatic cSCC
Question 2DermatologyMedium
A 60-year-old male farmer with extensive UV exposure has a 2-year history of multiple rough, scaly, erythematous, sandpaper-like 5-10 mm lesions on his scalp, face, and dorsal hands. He has had 2 actinic keratoses removed by cryotherapy in the past and now has over 20 lesions. Which of the following is the most appropriate management to address field cancerization?
  • AAnnual clinical observation and photoprotection
  • BOral nicotinamide 500 mg taken twice daily
  • CTopical 5-fluorouracil 5% applied twice daily
  • DRepeat liquid nitrogen cryotherapy every 3 months
Reveal answer & full explanation
Correct answer: C — Topical 5-fluorouracil 5% applied twice daily
  • AAnnual clinical observation and photoprotection
  • BOral nicotinamide 500 mg taken twice daily
  • CTopical 5-fluorouracil 5% applied twice daily✓
  • DRepeat liquid nitrogen cryotherapy every 3 months

Why Topical 5-fluorouracil 5% applied twice daily is correct

  • Actinic keratoses (AKs) are precancerous lesions caused by UV-induced p53 mutations; per-lesion progression to squamous cell carcinoma (SCC) is low (under 1% per year), but most cutaneous SCCs arise from AKs.
  • Field cancerization means the entire UV-exposed area harbors subclinical change, so treating only visible lesions leaves the surrounding field at risk.
  • Topical 5-FU is the most effective single-agent field-directed therapy (50-90% clearance) because it treats subclinical AKs across the whole photodamaged area, not just palpable ones.
  • A course is typically applied twice daily for 2-4 weeks; a brisk inflammatory reaction is expected and necessary for efficacy.

Why the others are wrong

  • Annual clinical observation and photoprotection — right-concept-wrong-setting: photoprotection is appropriate adjunctively, but with 20+ lesions and prior AKs, passive observation undertreats an actively transforming field.
  • Oral nicotinamide 500 mg taken twice daily — right-concept-wrong-goal: nicotinamide is oral chemoprevention that modestly lowers the rate of new AKs and keratinocyte carcinomas in high-risk patients (ONTRAC trial), but it does not clear the AKs and subclinical disease already present across the field, and its benefit fades once it is stopped.
  • Repeat liquid nitrogen cryotherapy every 3 months — confused-with lesion-directed therapy: cryotherapy excels for isolated, thick, or recalcitrant AKs but treats only visible spots, not the surrounding subclinical field.

Additional high-yield points

  • Other field-directed therapies: imiquimod 5% (TLR-7 agonist) 2x/week x16 weeks or imiquimod 3.75% daily in two 2-week cycles; photodynamic therapy (ALA or MAL plus light) with excellent cosmetic outcome; tirbanibulin 1% ointment daily x5 days on the face or scalp.
  • Photoprotection: SPF >50 sunscreen and UPF clothing to slow accrual of new UV damage.
🔒 Free preview limit reached

Keep comparing — start your free trial

You've used your 2 free previews. Create your free account to see the full Squamous Cell Carcinoma vs Actinic Keratosis comparison — plus all 514 diagnosis outlines, 7,200+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.

Start your 7-day free trial → Sign in
Free to start · No credit card · Cancel anytime

Side-by-side comparison

FeatureSquamous Cell CarcinomaActinic Keratosis
At a glanceSecond most common skin cancer; UV-driven keratinocyte malignancy with real metastatic potential, especially in immunosuppressed.UV-induced precancerous keratinocyte lesion on sun-damaged skin; low per-lesion risk of progression to invasive SCC, but the precursor of most cutaneous SCCs.
Classic presentationHyperkeratotic indurated nodule with central ulceration on sun-damaged skin of an older adult, often arising from a pre-existing actinic keratosis.; Often asymptomatic; new growth, non-healing 'sore', or growth in a chronic scar/ulcer; Tenderness, bleeding, crusting; Pain, paresthesia, motor weakness → perineural invasion; Bowen disease…Gritty sandpaper-textured pink scaly papule on a sun-damaged background of an older fair-skinned adult.; Usually asymptomatic; some lesions tender or pruritic with friction; Sandpaper texture often felt before lesion is seen — diagnostic clue; Patient concern about cosmetic appearance; Rough, scaly, erythematous papule or macule on…
Workup / key labsHistopathologic confirmation; AJCC 8th edition staging + NCCN/BWH risk stratification; Skin biopsy (shave, punch, or excisional) — tissue diagnosis required; Histopathology determines depth, differentiation (well/moderate/poor), perineural invasion, and high-risk featuresClinical: characteristic rough scaly papule on sun-damaged skin of older adult; biopsy if suspicion of SCC.; Clinical diagnosis sufficient for typical lesions; Skin biopsy if atypical features (induration, ulceration, bleeding, rapid growth, >1 cm, tenderness, refractory to therapy) — to exclude invasive SCC; Dermoscopy: strawberry…
ImagingLymph node ultrasound + FNA if palpable lymphadenopathy or high-risk tumor; CT/MRI for large tumors, perineural invasion symptoms, deep tissue/bone involvement; PET/CT for staging in advanced disease; Sentinel lymph node biopsy considered for high-risk SCC (>2 cm, >6 mm depth, poor differentiation, perineural invasion,…Not indicated
First-line treatmentLow-risk primary cutaneous SCC: surgical excision with 4-6 mm clinical margins (cure rate >95%); Mohs micrographic surgery (preferred for high-risk SCC): face/H-zone, ears, lips, genitalia, perineural invasion, recurrent, >2 cm, depth >6 mm, poor differentiation, immunosuppressed host; ED&C for small (<1 cm) low-risk SCC in situ on…Lesion-directed therapy for isolated AKs:; • Cryotherapy with liquid nitrogen — 5-10 seconds per lesion; most common; cure ~67-83%; possible hypopigmentation; • Curettage ± electrodessication for hypertrophic or persistent AKs; Field therapy for multiple AKs or field cancerization (preferred when ≥6-10 AKs in an area):; • 5-fluorouracil…

Drill Squamous Cell Carcinoma vs Actinic Keratosis questions on FirstPassPA

Turn this comparison into retention. 7,200+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Full outlines

Squamous Cell Carcinoma Actinic Keratosis All 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.